These results are in line with a study by Llinàs-Arias et al. suggesting SVIP expression is upregulated in breast cancer, prostate cancer, lung cancer, and skin cancer while significantly decreased in head and neck tumors [18]. This evidence concerns the gene SVIP and Familial prostate cancer.